We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Investigator Cited for Protocol Violations in Phase III Trial
Investigator Cited for Protocol Violations in Phase III Trial
March 18, 2009
A clinical investigator in a Phase III trial of a treatment for erosive esophagitis violated the study protocol and enrolled patients without first reviewing their laboratory test results as required, according to an FDA warning letter.